📍 LONDRA, BİRLEŞİK KRALLIK
16.11.2026 14:08 UTC
UK Focus: Johnson & Johnson buys eye disease biotech for up to $3.3bn
Verified reporting indicates that johnson & Johnson buys eye disease biotech for up to $3.3bn. Additional details from primary dispatches note: Drugmaker’s acquisition of Ollin Biosciences is latest in glut of deals in b...